MetaOptima Technology Inc.

MetaOptima Technology Inc. is a dermatology-focused medical technology company specializing in intelligent skin imaging and analytics platforms. The company develops AI-powered solutions for skin cancer detection, melanoma screening, and dermatological documentation. Its primary product offerings include OptimaScan, a mobile 3D total body photography system capable of full-body imaging in under one minute with 360° rotating arm capture and 48MP resolution, integrated with AI analysis; DermEngine, an advanced cloud-based platform for skin imaging, analytics, and clinical documentation used by medical professionals globally; and MoleScope, a patient-facing skin imaging device with smartphone integration for personal skin monitoring. MetaOptima's technology leverages artificial intelligence for enhanced diagnostic accuracy and workflow efficiency in dermatology practices, surgical centers, and skin cancer screening programs. The company serves dermatologists, surgical centers, melanoma diagnostic centers, and healthcare networks across Australia, New Zealand, Canada, and internationally. Products integrate seamlessly across the company's ecosystem, enabling standardized documentation, longitudinal tracking, and AI-assisted analysis. MetaOptima has demonstrated partnerships with major healthcare organizations, research institutions, and consumer health brands including L'Oréal, La Roche-Posay, Sonic Healthcare, and Melanoma Institute Australia. The company participates in government innovation programs and attends major international medical conferences including MEDICA and EADV Congress, indicating regulatory engagement and clinical validation efforts.